Study of Neonatal Exposure to Estrogenic and Androgenic Endocrine Disruptors by Normal-Phase HPLC
Author(s):
Masahiro Kuwada, Rei Kawashima, Kazuo Nakamura, Hideyo Hasumi and Jun Maki
Pages 126-131 (6)
Abstract:
Neonatal exposure to estrogenic and androgenic endocrine disruptors induces developmental abnormalities in
the female reproductive system. To investigate whether neonatal exposure affects oogenesis in juvenile and pubertal
ovary, Sprague-Dawley rat pups were given estrogen or various endocrine disruptors by a single injection on the day of
birth at concentrations ranging between 2 mM to 40 mM, and sacrificed on day 21 (juvenile) or 50 (puberty). The ovaries
were weighed and examined histologically at each stage. Further, 17 β-estradiol synthesis of oogenesis was analyzed using
normal-phase high-performance liquid chromatography. Neonatal exposure to 17 β-estradiol, diethylstilbestrol and estrogen
receptor inhibitors significantly reduced ovary weights, although estrogen receptor inhibitors were completely restored
by 17 β-estradiol synthesis during puberty.
Keywords:
Endocrine disruptor, neonatal exposure, ovary, oogenesis, 17 β-estradiol, estrogen receptor.
Affiliation:
Department of Nutrition, Faculty of Human Health, Hachinohe University, 13-98 Mihono, Hachinohe, Aomori 031-0844, Japan.